The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Aggregate verification data across the directory, with caveats

This is a generated summary. It shows the 9 most-liked posts from a topic of 75, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
JH
j.hartmannTL2 Moderator15 Jun 2026#1

On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion.

Structured report rather than an opinion, following the format the maintainers asked for.

  • Compound: retatrutide
  • Independent testing: VendorInvestigate
  • Method as reported: reversed-phase HPLC, 214 nm
  • Result: 97% area
  • Certificate figure for the same lot: 98.9%

I am not drawing a conclusion about the supplier from one lot and I would ask that nobody else does either. I am adding a data point to a record.

47 likes 1mo
LV
l.vermeulenTL2 Moderator25 Jun 2026#12

post #11 answers the question as asked. The question underneath it is different.

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

33 likes 1mo
AD
ambient_draftTL3Regular2 Jul 2026#24

I read post #22 twice before replying, because I had assumed the opposite.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

27 likes 26d
TI
trough_indexTL3Regular5 Jul 2026#30

Worth separating two things that post #26 runs together.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

28 likes 22d
AW
a.weissTL2 Moderator6 Jul 2026#32
e.kjeldsen, post #13: Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time. VendorInvestigate reviews are documentation assessments. We cite all four because they answer different questions. Go to post

Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth more than self-selected ones.

25 likes in reply to #13 21d
SG
s.grahameTL2Member12 Jul 2026#43

Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.

23 likes 16d
B
BirkelandTL3Regular14 Jul 2026#47

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

31 likes 14d
JV
j.vogelTL2 Moderator17 Jul 2026#52

How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly ensures results are interpretable.

30 likes 11d
QZ
q.zhao_qaTL3Quality assurance26 Jul 2026#71
Birkeland, post #47: Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up. Go to post

Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is usually faster than testing.

28 likes in reply to #47 2d

Read the full topic (75 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Publishing an inconvenient result: a case study
On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked for.…
DBDTRVUCAV+59 70 992 11mo
Submitting a sample: the process end to end
On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. I would like to talk about documentation quality as a signal, separately from product quality.…
DOEVABKPLG+99 114 29k 21h
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
MARAMAVDNA+12 16 41k 4mo
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal,…
PMPMDBAACB+22 26 23k 17mo
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following…
PWGEJHKORM+117 130 3.3k 14mo

Related topics — sharing the tags Medutest, blind sampling, PeptideMeter

TopicParticipantsRepliesViewsActivity
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
MARAMAVDNA+12 16 41k 4mo
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
SZMJIRHGB+129 153 7.3k 5mo
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold?
Asking directly, because I could not find a straight answer: How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Structured report rather than an opinion, following the…
EDKSVCDBS+24 28 8k 1mo
Blind submission and why it changes minds
Blind submission and why it changes minds — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked for.…
THMVNGNSGT+91 96 1.1k 21mo
[2026 update] What a purity-only report leaves out
The question in the title: What a purity-only report leaves out I will give what I have already checked below so nobody repeats it. Structured report rather than an opinion, following the format the…
BCKMMHLVN+97 103 5.2k 3mo